1. Signaling Pathways
  2. Neuronal Signaling
  3. Cholinesterase (ChE)

Cholinesterase (ChE)

(ChE)

Cholinesterase (ChE) is a family of enzymes present in the central nervous system, particularly in nervous tissue, muscle and red cells, which catalyze the hydrolysis of the neurotransmitter acetylcholine into choline and acetic acid, a reaction necessary to allow a cholinergic neuron to return to its resting state after activation. It is one of many important enzymes needed for the proper functioning of the nervous systems of humans.

There are two types: acetylcholinesterase (AChE, acetylcholine hydrolase) and butyrylcholinesterase (BChE, acylcholine acylhydrolase), also known as nonspecific cholinesterase or pseudocholinesterase. AChE is primarily found in the blood on red blood cell membranes, in neuromuscular junctions, and in neural synapses, while BChE is produced in the liver and found primarily in plasma. The difference between the two types of cholinesterase is their relative preferences for substrates: AChE hydrolyzes acetylcholine faster while BChE hydrolyzes butyrylcholine faster.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B2244
    Tacrine hydrochloride (hydrate)
    Inhibitor 99.98%
    Tacrine hydrochloride (hydrate) is an inhibitor of both acetyl (AChE) and butyryl-cholinestrase (BChE) with IC50s of 31 nM and 25.6 nM, respectively.
    Tacrine hydrochloride (hydrate)
  • HY-N8290
    Lactupicrin
    Inhibitor 99.97%
    Lactupicrin (Lactucopicrin) exhibits analgesic, sedative, antimalarial activities and atheroprotective effect. Lactupicrin inhibits acetylcholinesterase (AChE) with an IC50 of 150.3 μM. Lactupicrin is an orally active characteristic bitter sesquiterpene lactone.
    Lactupicrin
  • HY-B1626A
    Demecarium Bromide
    Inhibitor
    Demecarium Bromide (BC-48) is a potent cholinesterase inhibitor, with an apparent affinity (Kiapp) of 0.15 μM. Demecarium Bromide (BC-48) is used as a glaucoma agent.
    Demecarium Bromide
  • HY-B0841
    Acephate
    Inhibitor ≥98.0%
    Acephate is a broad-spectrum anticholinesterase insecticide. Acephate acts via inhibiting AChE (AChE.html" class="link-product" target="_blank">Cholinesterase (ChE)) activity of insects. Acephate is used for control of several species of insects in agriculture and in horticulture.
    Acephate
  • HY-N2320
    Physostigmine hemisulfate
    Inhibitor ≥99.0%
    Physostigmine hemisulfate (Eserine hemisulfate) is a reversible acetylcholinesterase (AChE) inhibitor. Physostigmine hemisulfate can crosses the blood-brain barrier and stimulates central cholinergic neurotransmission. Physostigmine hemisulfate can reverse memory deficits in transgenic mice with Alzheimer's disease. Physostigmine hemisulfate is also an antidote for anticholinergic poisoning.
    Physostigmine hemisulfate
  • HY-116583
    Resorufin butyrate
    ≥99.0%
    Resorufin butyrate is a fluorogenic substrate for triglyceride lipases and cholinesterase (Ex=570 nm, Em=580 nm).
    Resorufin butyrate
  • HY-N0241
    Rhodionin
    Inhibitor 98.78%
    Rhodionin, isolated from the root of Rhodiola crenulata, is a specific non-competitive cytochrome P450 2D6 inhibitor with an IC50 of 0.761 μM and a Ki of 0.769 μM. Rhodionin exhibits potent, dose-dependent inhibitory effects on acetylcholinesterase (AChE) with IC50 ranged from 57.50 to 2.43 μg/mL. Rhodionin exhibits potent DPPH free radical scavenging activities, with an IC50 of 19.49 μM.
    Rhodionin
  • HY-16934
    ML352
    Inhibitor 99.78%
    ML352 is a noncompetitive inhibitor of the presynaptic choline transporter (CHT) with Ki values of 92 and 166 nM for HEK293 cells expressing human CHT and mouse forebrain synaptosomes, respectively.
    ML352
  • HY-100907
    (±)-Acetylcarnitine chloride
    Antagonist 99.60%
    (±)-Acetylcarnitine chloride (Acetyl dl-carnitine chloride) is a weak cholinergic agonist with cholinergic properties. (±)-Acetylcarnitine chloride is an important intermediate in lipid metabolism.
    (±)-Acetylcarnitine chloride
  • HY-B1277
    Trihexyphenidyl hydrochloride
    Antagonist 99.93%
    Trihexyphenidyl hydrochloride is a potent and selective M1 muscarinic receptor antagonist. Trihexyphenidyl hydrochloride shows anticholinergic activity, and can be used for Parkinson syndrome or dystonia research.
    Trihexyphenidyl hydrochloride
  • HY-N1919
    Ajmalicine
    Inhibitor 99.39%
    Ajmalicine (Raubasine) is a potent adrenolytic agent which preferentially blocks α1-adrenoceptor. Ajmalicine is an reversible but non-competitive nicotine receptor full inhibitor, with an IC50 of 72.3 μM. Ajmalicine also can be used as anti-hypertensive, and serpentine, with sedative activity.
    Ajmalicine
  • HY-N0702
    Tenuifolin
    Inhibitor 99.24%
    Tenuifolin is effective and has a protective action. Tenuifolin inhibits β-secretase decreases Aβ protein secretion, suppresses Aβ25-35 secretion, and subsequently caspase-3 and caspase-9 become active. Tenuifolin's ability to lower AChE activity, increase at the same time, increase the ability of the upper glands, and improve the ability to read and remember. Research on tenuifolin's potential for use in urinary disease (AD).
    Tenuifolin
  • HY-N8728
    Aposcopolamine
    98.44%
    Aposcopolamine is an alkaloid that can be isolated from Datura ferox. Aposcopolamin can closely binds with ACHE, ADRA2A and CHRM2. Aposcopolamine can be used for the research of Alzheimer's disease.
    Aposcopolamine
  • HY-B1885
    Fenitrothion
    Inhibitor 99.43%
    Fenitrothion is a broad-spectrum and orally active insecticide/acaricide. Fenitrothion inhibits cholinesterase, AMPKα and IRS1/PI3K/AKT. Fenitrothion causes Apoptosis, reduces SOD activity. Fenitrothion shows insecticidal effect against Rhyzopertha dominica and Tribolium castaneum adults. Fenitrothion is widely used in cotton crops, vegetable crops, fruit crops and field crops, especially rice. Fenitrothion can be used for brain and spleen toxicology studies.
    Fenitrothion
  • HY-17388
    (±)-Huperzine A
    Inhibitor 98.73%
    (±)-Huperzine A, an active Lycopodium alkaloid extracted from traditional Chinese herb, is a potent, selective and reversible acetylcholinesterase (AChE) inhibitor and has been widely used in China for the treatment of Alzheimer's disease (AD).
    (±)-Huperzine A
  • HY-124957
    β-NETA
    Inhibitor ≥98.0%
    β-NETA is a potent and noncompetitive choline acetyltransferase (ChA; IC50=76 μM) and cholinesterase (ChE; IC50=40 μM) inhibitor. β-NETA weakly inhibits acetylcholinesterase (AChE; IC50=1 mM).
    β-NETA
  • HY-118165
    Phenthoate
    Inhibitor 98.71%
    Phenthoate is an organophosphorus pesticide having low toxicity in animals. Phenthoate is also a AChE inhibitor.
    Phenthoate
  • HY-W159754
    Chavicol
    Inhibitor
    Chavicol (p-Hydroxyallylbenzene, compound 6) can inhibit acetylcholinesterase (Cholinesterase (ChE)), with an IC50 of 7.42 μM. Chavicol has anti-cancer activity and can suppress the growth, survival, migration, and invasion of cancer cells. Chavicol cytotoxic effect is significant, approximately 31 μg/mL in A-549 cells.
    Chavicol
  • HY-Y0320R
    Dimethyl sulfoxide (Standard)
    Inhibitor 99.99%
    Dimethyl sulfoxide (Standard) is the analytical standard of Dimethyl sulfoxide. This product is intended for research and analytical applications. Dimethyl sulfoxide (DMSO) is an aprotic solvent that dissolves both polar and nonpolar compounds. Dimethyl sulfoxide has anti-freezing and bacteriostatic properties.
    Dimethyl sulfoxide (Standard)
  • HY-100620
    RPR121056
    Inhibitor 99.59%
    RPR121056 (APC) is a metabolite of Irinotecan (CPT-11), which is generated by CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE.
    RPR121056
Cat. No. Product Name / Synonyms Application Reactivity

AChE

BChE

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Cholinesterase (ChE) Inhibitors, Agonists, Antagonists, Activators & Chemicals
Product NameAChEBChEPurity    
Donepezil Hydrochloride
AChE
 99.92%
Donepezil
AChE
 99.87%
TMPyP4 tosylate
AChE
 ≥98.0%
p-Xylene bis(pyridinium bromide)
hAChE, IC50: 1540 μM
BChE, IC50: 529 μM
99.60%
Imperatorin
AChE
BChE
98.72%
Rivastigmine
AChE
BChE
99.93%
Galanthamine
AChE
 99.96%
Garcinol
AChE
BChE
≥99.0%
α-NETA
AChE
 ≥98.0%
Scopoletin
AChE
 99.89%
Linarin
AChE
 98.00%
Physostigmine salicylate
AChE
 99.74%
Rivastigmine tartrate
AChE
 99.03%
Isoimperatorin
AChE
 99.61%
(-)-Huperzine A
AChE
 99.74%
Tacrine hydrochloride
AChE
BChE
99.95%
Sinapine
AChE
 99.96%
Timosaponin AIII
AChE
 99.73%
Chlorpyrifos
AChE
 99.94%
Epiberberine chloride
AChE
BChE
99.02%
Pyridostigmine bromide
AChE
 99.93%
Tacrine
AChE, IC50: 109 nM
 99.91%
Corydaline
AChE
 99.70%
Ethopropazine hydrochloride
AChE
BChE
99.66%
Jatrorrhizine chloride
AChE
 99.88%
Corynoline
AChE
 99.12%
(-)-Carvone
eel AChE, Ki: 2.19 mM
 99.91%
Nodakenin
AChE
 98.76%
Cyanidin-3-O-galactoside chloride
AChE
 99.20%
Itopride hydrochloride
AChE
 99.84%
Pralidoxime chloride
AChE
 99.73%
N-p-trans-Coumaroyltyramine
AChE
 98.78%
Coumaran
AChE
 99.54%
Galanthamine hydrobromide
AChE
 99.93%
Aaptamine
AChE, IC50: 0.23 μg/mL
BChE, IC50: 1.38 μg/mL
99.71%
Rhodiosin
AChE
 99.36%
Profenofos
AChE
 
Sinapine thiocyanate
AChE
 99.74%
Tacrine hydrochloride (hydrate)
AChE
BChE
99.98%
Acephate
AChE
 ≥98.0%
Physostigmine hemisulfate
AChE
 ≥99.0%
Rhodionin
AChE
 98.78%
Tenuifolin
AChE
 99.24%
(±)-Huperzine A
AChE
 98.73%
β-NETA
AChE
 ≥98.0%
Phenthoate
AChE
 98.71%
RPR121056
AChE
 99.59%
Phenserine
AChE
 99.55%
Jatrorrhizine hydroxide
AChE
 98.07%
Pralidoxime iodide
AChE
 ≥98.0%
Mca-YVADAP-Lys(Dnp)-OH TFA
AChE
 99.45%
Pteryxin 
BChE
99.96%
PCS1055 dihydrochloride
AChE
 98.88%
Manghaslin
AChE
 98.56%
Picfeltarraenin IA
AChE
 99.83%
Drofenine hydrochloride 
BChE
98.10%
Picfeltarraenin IB
AChE
 98.53%
Fenchlorphos
AChE
 99.87%
Ladostigil hydrochloride
AChE, IC50: 31.8 μM
 99.94%
Violanthin
AChE
 
Acotiamide monohydrochloride trihydrate
AChE
 99.79%
Benactyzine hydrochloride 
BChE, Ki: 0.01 mM
99.02%
Pirimiphos-methyl
AChE
 98.00%
Galanthaminone
AChE
 99.85%
BChE-IN-17
eel AChE, IC50: 686.4 μM
eqBCHE, IC50: 10.5 nM
hBCHE, IC50: 32.5 nM
99.07%
Neoeriocitrin
AChE
 99.93%
Zanapezil free base
AChE
 99.23%
Penconazole
AChE
 98.91%
PE154
AChE, IC50: 280 pM
BChE, IC50: 16 nM
99.01%
Zanapezil fumarate
AChE
 99.63%
Jatrorrhizine
AChE
 
Ebeiedinone
AChE
BChE
99.51%
P11149
AChE
 99.23%
Galanthamine N-Oxide
AChE
BChE
99.90%
Pitofenone hydrochloride
AChE
 99.88%
Epiberberine
AChE
BChE
98.46%
Pirimicarb
AChE
 99.50%
PCS1055
hAChE, IC50: 120 nM
 98.02%
Y13g dihydrochloride
AChE
 99.89%
Swertianolin
AChE
 99.54%
Zanapezil
AChE
 99.63%
Isoprocarb
AChE
 99.12%
Dihydrowithaferin A
AChE
 99.57%
Sophoflavescenol
AChE
BChE
98.78%
(±)-Marmesin
AChE
 
ASS234
AChE, IC50: 350 nM
BChE, IC50: 460 nM
99.6%
SD-6
hAChE, IC50: 0.907 μM
hBCHE, IC50: 1.579 μM
≥98.0%
Polygalacic acid
AChE
 98.92%
Territrem B
AChE
 
Isorosmanol
AChE
 99.40%
AChE/BChE-IN-10
AChE, IC50: 0.176 μM
BChE, IC50: 0.47 μM
99.67%
Anatoxin-a
AChE
 
Lucidadiol
AChE, IC50: 31.03 μM
BChE, IC50: 156.27 μM
≥98.0%
Z32439948 
BChE, IC50: 1.4 μM ([1])
HDAC6-IN-5
AChE, IC50: 0.72 μM
 
AChE/BChE-IN-1
AChE
BChE
ZLMT-12
AChE, IC50: 19.023 μM
BChE, IC50: 2.768 μM
AChE-IN-72
AChE, IC50: 0.59 μM
BChE, IC50: 5.02 μM
hAChE-IN-6
hAChE, IC50: 0.16 μM
hBCHE, IC50: 0.69 μM
SB-1436
EeAChE, IC50: 0.176 μM
EeAChE, Ki: 0.046 μM
eqBCHE, IC50: 0.37 μM
eqBCHE, Ki: 0.115 μM
hAChE-IN-9
hAChE, IC50: 0.05 μM
hBCHE, IC50: 2.85 μM
AChE-IN-14
AChE
 
AChE/BChE-IN-18
AChE, IC50: 0.315 μM
 
BChE-IN-6 
BChE, Ki: 0.182 μM
AChE-IN-81
AChE, IC50: 3.7 μM
AChE, Kd: 5.37 μM
 
Methylene Violet 3RAX
AChE, Ki: 1.58 μM
BChE, Ki: 0.51 μM
AChE-IN-60
AChE, IC50: 27 nM
BChE, IC50: 43 nM
Azamethiphos
AChE
 
AChE-IN-44
AChE
 
K203
AChE
 
AChE-IN-28
AChE, IC50: 0.2 nM
 
ChEs/MAOs-IN-2
AChE, IC50: 0.30 μM
BChE, IC50: 0.40 μM
Isogarcinol
AChE, IC50: 1.13 ± 0.0 μM
BChE, IC50: 8.30 ± 0.0 μM
BChE-IN-36
EeAChE, IC50: 72.1 nM
eqBCHE, IC50: 4.2 nM
Stemoninine
hAChE, IC50: 5.52 μM
 
AChE/BuChE-IN-5
AChE, IC50: 46.9 nM
RatBuChE, IC50: 3.5 nM
Dual AChE-MAO B-IN-1
AChE
 
Kuwanon U
AChE, IC50: 19.69 μM
AChE, IC50: 6.48 μM
BChE, Ki: 10.11 μM
BChE, Ki: 9.59 μM
AChE/BChE/MAO-B-IN-3
hAChE, IC50: 0.0473 μM
hBCHE, IC50: 0.0782 μM
hBChE-IN-2 
hBCHE, IC50: 0.67 μM
Y13g
AChE
 
AChE-IN-35
AChE, IC50: 5.88 μM
 
Z164597606 
eqBCHE, IC50: 1.3 μM
hBCHE, IC50: 1.7 μM
Pralidoxime
AChE
 
Xanthohumol I
AChE
BChE
SBN-284
EeAChE, IC50: 0.37 μM
hAChE, IC50: 0.31 μM
eqBCHE, IC50: 0.29 μM
MAO-IN-6
AChE, IC50: 4.48 μM
BChE, IC50: 17.03 μM
AChE/BACE1/GSK3β-IN-1
AChE, IC50: 1 μM
 
AChE/MAO-IN-1
hAChE, IC50: 0.0248 μM
 
Blestrin D 
BChE, IC50: 8.1 μM
AChE-IN-22
AChE
 
eeAChE-IN-2
AChE
 
AChE/BChE-IN-16
hAChE, IC50: 30 nM
hBCHE, IC50: 48 nM
hAChE/Aβ1-42-IN-1
AChE
 
Protriptyline
AChE, IC50: 0.06 mM
 
AChE/hCA I-IN-1
AChE, IC50: 302.2 nM
 
BChE-IN-19 
BChE, IC50: 0.04 μM
MAO-B-IN-7
hAChE, IC50: 41 nM
 
AChE/Aβ-IN-3
AChE, IC50: 1.29 μM
 
BuChE-IN-7 
hBCHE, IC50: 40 nM
eqBCHE, IC50: 80 nM
K027
AChE
BChE
hAChE/hBuChE/GSK-3β-IN-1
hAChE, IC50: 28.88 nM
hBCHE, IC50: 131.90 nM
AChE/BChE/MAO-B-IN-2
AChE, IC50: 83.9 nM
BChE, IC50: 31.2 nM
Bis-(-)-8-demethylmaritidine
AChE
 
Carbonic anhydrase/AChE-IN-1
AChE, Ki: 5.07 nM
 
hAChE-IN-2
hAChE, IC50: 0.71 μM
 
BChE-IN-33 
BChE, IC50: 14.78 nM
BChE-IN-32 
hBCHE, IC50: 0.109 μM
AChE-IN-75
AChE
 
AChE/MAO-B-IN-3
hAChE, IC50: 0.0257 μM
 
Picfeltarraegenin X
AChE
 
MR33317
AChE, IC50: 41 nM
 
BChE-IN-16 
hBCHE, IC50: 3.8 nM
H3R antagonist 4
hAChE, IC50: 9.73 μM
EeAChE, IC50: 7.04 μM
eqBCHE, IC50: 13.40 ~ 88 μM
Multitarget AD inhibitor-2
AChE, IC50: 0.14 μM
BChE, IC50: 11.6 μM
hAChE/hBACE-1-IN-1
hAChE, IC50: 0.076 μM
hBACE-1, IC50: 0.23 μM
hBCHE, IC50: 1.204 μM
K1833
hAChE, IC50: 58 μM
hBCHE, IC50: 0.57 μM
AChE/CA I-IN-1
AChE, Ki: 1.85 μM
 
Desoxypeganine
AChE, IC50: 17 μM
BChE, IC50: 2 μM
BChE-IN-35 
BChE
AChE/BChE-IN-12
EeAChE, IC50: 2.57 ± 0.3 μM
eqBCHE, IC50: 3.26 ± 0.1 μM
Bisnorcymserine 
BChE, IC50: 0.228 nM
BChE-IN-12 
BChE, IC50: 2.3 μM
hCA I-IN-4
AChE, Ki: 21.21 nM
BChE, Ki: 7.65 nM
hAChE/hBACE-1-IN-4
hAChE, IC50: 0.283 μM
hBCHE, IC50: 0.231 μM
AChE-IN-19
AChE
 
AChE-IN-77
AChE, IC50: 29.46 μM
 
Lycodoline 
BChE, IC50: 667 μM
KBR 2822
AChE
 
AChE-IN-8
AChE
 
CUR-IPA
hAChE, IC50: 59.30 μM
hBCHE, IC50: 60.66 μM
AChE/BChE-IN-25
hAChE, IC50: 7.9 nM
eqBCHE, IC50: 0.79 nM
AChE-IN-46
AChE
 
Dual AChE-MAO B-IN-3
EeAChE, IC50: 0.58 ± 0.0 μM
 
BuChE-IN-12 
BChE, IC50: 0.52 nM
Broussonin A 
BChE, IC50: 4.16 μM
Memoquin
hAChE, IC50: 1.55 nM
 
S21-1011 
eqBCHE, IC50: 0.059 μM
hBCHE, IC50: 0.162 μM
AChE-IN-17
AChE
 
CEase-IN-1
AChE, IC50: 45.9 μM
 
AChE-IN-5
AChE
 
ChE/Aβ1-42-IN-1
AChE
 
AChE/BChE-IN-11
AChE, IC50: 70 μM
BChE, IC50: 71 μM
AChE/BuChE-IN-1
AChE
 
AChE/BChE-IN-17
AChE, IC50: 125.06 ± 2 nM
BChE, IC50: 119.68 ± 2 nM
AChE/BChE-IN-23
hAChE, IC50: 0.91 μM
eqBCHE, IC50: 1.19 μM
hBCHE, IC50: 1.02 μM
AChE-IN-69
AChE, IC50: 1.67 μM
 
BChE-IN-39
AChE, IC50: 3.98 μM
BChE, IC50: 0.08 μM
Kokusaginine
AChE, IC50: 28.2 μM
 
BChE-IN-31
AChE, IC50: 5.9 μM
BChE, IC50: 65 nM
AChE/BChE-IN-20
AChE, IC50: 34.81 μM
BChE, IC50: 20.66 μM
NDs-IN-1
hAChE
hBCHE
AChE/BChE/MAO-B-IN-5
AChE, IC50: 0.24 μM
BChE, IC50: 6.29 μM
BuChE-IN-16 
BChE, IC50: 0.33 μM
BChE-IN-5
AChE
BChE
Flucopride
AChE, IC50: 24 nM
 
hAChE-IN-10
hAChE, IC50: 6.34 nM
 
AChE-IN-85
AChE, IC50: 0.083 μM
 
tau/Aβ40 aggregation-IN-1
hAChE, IC50: 16.10 μM
equine serum BChE, IC50: 0.96 μM
AChE/BChE-IN-6
hAChE, IC50: 2.248 μM
hBCHE, IC50: 0.809 μM
AChE-IN-24
AChE
 
AChE-IN-51
AChE, IC50: 84 nM
BChE, IC50: 97 nM
Artanin
AChE, IC50: 51 μM
 
AChE/BuChE/MAO-B-IN-1
hAChE, IC50: 4.8 μM
hBCHE, IC50: 13.7 μM
CL-13 
BChE, IC50: 1.15 μM
Monarsen
AChE
 
AChE-IN-12
AChE
 
AChE/BuChE-IN-3
AChE, IC50: 0.65 μM
BChE, IC50: 5.77 μM
AChE/BChE-IN-24
AChE, IC50: 16.38 μM
BChE, IC50: 10.44 μM
hAChE-IN-8
hAChE, IC50: 0.486 μM
hBCHE, IC50: 0.542 μM
AChE-IN-64
AChE, IC50: 36.9 μM
 
eeAChE-IN-3
EeAChE, IC50: 0.54 μM
RatAChE, IC50: 0.49 μM
RatBuChE, IC50: 8.54 μM
BChE-IN-26
AChE, Ki: 35 μM
BChE, Ki: 1.6 μM
α-Glucosidase-IN-68
AChE, IC50: 0.774 μM
BChE, IC50: 0.793 μM
TRV-7019 
BChE
99.64%
AChE-IN-21
EeAChE, IC50: 2.66 nM
RatBuChE, IC50: 19.10 μM
AChE-IN-67
AChE, IC50: 0.033±0.00 μM
BChE, IC50: >100 μM
AChE/BChE-IN-26 
eqBCHE, IC50: 4.11 μM
AChE/BuChE-IN-6
AChE, IC50: 1.24 μg/mL
BChE, IC50: 1.85 μg/mL
MAO-A/B-IN-3
AChE, IC50: 1370 nM
 
AChE-IN-52
AChE
 
BChE-IN-15
hAChE, IC50: 558.6 nM
hBCHE, IC50: 1.76 nM
AChE-IN-59
AChE, IC50: 0.05 μM
BChE, IC50: 4.68 μM
Desoxypeganine hydrochloride
AChE, IC50: 17 μM
BChE, IC50: 2 μM
AChE/BChE-IN-3 hydrochloride
AChE
BChE
MR2938
AChE, IC50: 5.04 ± 0.7 μM
BChE, IC50: >20 μM
Pitofenone
AChE
 
BChE-IN-10 
BChE, IC50: 6.4 μM
AChE/MAO-B-IN-4
AChE
 
hCAI/II-IN-8
AChE, IC50: 46.27 ±0.7 nM
BChE, IC50: 43.38 ± 0. nM
Itopride
AChE
 
S16–1029 
eqBCHE, IC50: 11.35 nM
hBCHE, IC50: 48.1 nM
BChE-IN-11 
BChE, IC50: 2.1 ± 0.3 μM
Isoprocarb-d3
AChE
 
AChE/BuChE/MAO-B-IN-2
AChE, IC50: 5.3 μM
BChE, IC50: 12.4 μM
MHP 133
AChE, Ki: 69 μM
 
hBChE-IN-3
AChE, IC50: 7.4 nM
BChE, IC50: 1.9 nM
AChE/MAO-IN-2
AChE, IC50: 0.0224 μM
 
hAChE-IN-3
AChE, IC50: 0.44 μM
BChE, IC50: 0.08 μM
AChE/PDE4-IN-1
AChE, IC50: 0.28 μM
 
α-Amylase/α-Glucosidase-IN-7
AChE, IC50: 9.25 μM
BChE, IC50: 10.06 μM
hAChE-IN-1
hAChE, IC50: 1.09 μM
 
AChE-IN-63
hAChE, IC50: 0.103 μM
hBCHE, IC50: 10 μM
BChE-IN-34 
eqBCHE, IC50: 25 nM
AChE-IN-4
AChE, IC50: 24.1 μM
 
BChE-IN-22 
eqBCHE, IC50: 0.53 μM
BuChE-IN-11 
hBCHE, IC50: 0.44 μM
AChE-IN-20
AChE, IC50: 397.32 nM
AChE, Ki: 335.76 nM
 
BChE-IN-28
AChE, IC50: 3691 nM
BChE, IC50: 8 nM
BChE, Ki: 12.16 nM
AChE-IN-34
AChE, IC50: 3.98 μM
AChE, Ki: 0.044 μM
 
Dual AChE-MAO B-IN-4
AChE, IC50: 261 nM
 
Manumycin B
AChE, IC50: 15 mM
 
(Rac)-Sclerone
AChE, IC50: 192.65 ± 1 μg/mL
 
BChE/MAO-B-IN-1 
BChE, IC50: 375 nM
AChE-IN-82
EeAChE, IC50: 0.072 μM
eqBCHE, IC50: 9.81 μM
AChE-IN-68
hAChE, IC50: 0.040 ± 0. μM
hBCHE, IC50: >1000 μM
eeAChE-IN-1
AChE
 
AChE/BChE-IN-19
AChE, IC50: 21.45 nM
BChE, IC50: 18.42 nM
AChE-IN-55
EeAChE, IC50: 4.8 μM
 
Methyl ganoderate A acetonide
AChE
 
Isograndifoliol
AChE, IC50: 342.9 μM
BChE, IC50: 0.9 μM
hBChE-IN-1
EeAChE, IC50: 0.18 μM
hAChE, IC50: 7.84 ± 0.8 μM
hBCHE, IC50: 0.0070 ± 0 μM
equine serum BChE, IC50: 0.088 μM
AChE/Aβ-IN-4
AChE, IC50: 1.72 ± 0.1 μM
 
AChE-IN-47
AChE
 
AChE-IN-11
AChE
 
AChE-IN-10
AChE
 
Velnacrine
AChE, IC50: 3.27 μM
 
BChE-IN-38
AChE, Ki: 14.09 nM
BChE, Ki: 1.15 nM
AChE-IN-56
AChE
 
hAChE/hBACE-1-IN-2
hAChE, IC50: 0.113 μM
hBACE-1, IC50: 0.38 μM
hBCHE, IC50: 1.48 μM
BChE-IN-29
AChE, IC50: 0.74 μM
BChE, IC50: 0.075 μM
Benactyzine 
BChE, Ki: 0.01 mM
Donepezil N-oxide
AChE
 
WAY-361789
AChE
 
Buxbodine B
AChE, IC50: 50 μM
 
1,2-Didehydrotanshinone IIA 
BChE, IC50: 5.98 μM
AL284
AChE
 
T14-A24
AChE, Ki: 22 nM
 
7-Methoxytacrine
hAChE, IC50: 10.5 μM
hBCHE, IC50: 21 μM
TAE-1
AChE